Hemodynamics and Epoprostenol Use Are Associated With Thrombocytopenia in Pulmonary Arterial Hypertension
Authors:
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- The effect of prostacyclin agonists on the differentiation of phorbol ester treated human erythroleukemia cellsProstaglandins & Other Lipid Mediators, 2007
- A study of aspirin and clopidogrel in idiopathic pulmonary arterial hypertensionEuropean Respiratory Journal, 2006
- Aerosolized iloprost induces a mild but sustained inhibition of platelet aggregationEuropean Respiratory Journal, 2002
- Progressive splenomegaly after epoprostenol therapy in portopulmonary hypertensionLiver Transplantation and Surgery, 1999
- A Comparison of Continuous Intravenous Epoprostenol (Prostacyclin) with Conventional Therapy for Primary Pulmonary HypertensionNew England Journal of Medicine, 1996
- Cyclic‐AMP inhibits cell growth and negatively interacts with platelet membrane glycoprotein expression on the Dami human megakaryoblastic cell lineJournal of Cellular Physiology, 1995
- Thrombocytopenia and Lupus-Like Anticoagulant in a Patient with Peripheral Vascular Disease: Response to Infusion of ProstacyclinAngiology, 1985
- Platelet kinetics in congenital heart diseaseCardiovascular Research, 1982
- Platelet survival time in patients with hypoxemia and pulmonary hypertension.Circulation, 1977
- Häufigkeit und Pathogenese einer Thrombozytopenie bei HerzinsuffizienzDMW - Deutsche Medizinische Wochenschrift, 1976